Evidence map›Paper›PMID 27089237›Full record

ArticleJAMA2016

Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.

Douglas A Corley, Jennifer S Haas, Sarah Kobrin

Abstract read
In one paragraph

Article in JAMA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  5. Article
  6. Article
  7. Social Disadvantage, Healthcare Utilization, and Colorectal Cancer Screening: Leveraging Longitudinal Patient Address and Health Records Data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Article
  8. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland.
Jennifer S HaasDivision of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
Sarah KobrinHealth Systems and Interventions Research Branch, National Cancer Institute, Bethesda, Maryland.

Funding

Optimizing the use of colonoscopy for CRC screening in a large community-basedU54CA163262 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORLEY, DOUGLAS ALLEN, DOUBENI, CHYKE ABADAMA · 2011 to 2017
$9.6M
Parkland-UT Southwestern PROSPR Center Colon Cancer Screening in a Safety netU54CA163308 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SKINNER, CELETTE SUGG · 2011 to 2017
$8.0M
PROSPR Statistical Coordinating Center (PSCC)U01CA163304 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BARLOW, WILLIAM E, THORNQUIST, MARK · 2011 to 2017
$7.5M
Penn Center for Innovation in Personalized Breast ScreeningU54CA163313 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ARMSTRONG, KATRINA, SCHNALL, MITCHELL D. · 2011 to 2017
$7.4M
Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)U54CA163261 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA · 2011 to 2017
$7.3M
Vermont Screening Process Documentation UnitU54CA163303 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L · 2011 to 2017
$6.4M
Promoting personalized decisions for breast cancer screening for women AND theirU54CA163307 · NCI · DARTMOUTH COLLEGE · PI HAAS, JENNIFER S, ONEGA, TRACY · 2011 to 2017
$6.1M
Patient- and Practice-Centered Assessment of Self-CollectionU54CA164336 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WHEELER, COSETTE MARIE · 2011 to 2017
$5.5M
NCI NIH HHS 3U54CA163261-04S1NCI NIH HHS 3U54CA163262-04S1NCI NIH HHS 3U54CA163308-04S1NCI NIH HHS U01CA163304NCI NIH HHS U54CA163261NCI NIH HHS U54 CA163262NCI NIH HHS U54CA163262NCI NIH HHS U54CA163303NCI NIH HHS U54CA163307NCI NIH HHS U54CA163308NCI NIH HHS U54CA163313NCI NIH HHS U54CA164336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCenters for Disease Control and Prevention, U.S.Colorectal NeoplasmsEarly Detection of CancerFemaleHumansMaleMammographyMass ScreeningMedicaidMedicareProgram EvaluationStandard of CareUnited StatesUterine Cervical Neoplasms

Identifiers

PMID27089237
PMCPMC4920648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.